5GITLOW S E,BERTANI L M,RAUSEN A, et al. Diagnosis of neuroblastoma by quantitative and qualitative determination of catecholamine metabolites in urine [J]. Cancer, 1970,25 (6) :1377.
2Steven GD,Katherine K.Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.Nuclear Medicine Biol,2008,31:35-48.
3Simon T,Hero B,Hunneman DH,et al.Tumour markers are poor predictors for relapse or progress in neuroblastoma.Eur J Cancer,2003,39:1899-1903.
4Joshi VV,Cantor AB,Brodeur GM,et al.Correlation between morphologic and other prognostic markers of neuroblastoma.A study of histologic grade,DNA index,N-myc gene copy number,and lactic dehydrogenase in patients in the Pediatric Onoology Group.Cancer,1993,71:3173-3181.
5Pook JR,Villablanca JG,London WB,et al.Outcome of High-Risk Stage 3 Neuroblastoma With Myeloablative Therapy and 13-cis-Retinoic Acid:A Report From the Children's Oncologey Group.Pediatr Blood Cancer,2009,52:44-50.
6Matthay KK,Edeline V,Lumbroso J,et al.Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage Ⅳ neuroblastoma.J Clin Oncol,2003,21:2486-2491.
